FDA Alert: Efficacy Concerns with Atezolizumab Plus Paclitaxel for Breast Cancer

September 11, 2020

The FDA issued a safety alert about efficacy and potential safety concerns with a combination therapy being studied for the treatment of breast cancer.

Oncology Pharmacists Adapt to Serve Patients Amid Pandemic

September 10, 2020

Oncology pharmacists have implemented new ways to communicate with patients, schedule visits and treatments, and re-evaluate their medications regimens during the pandemic.

Study: No Link Between Antihypertensive Medications and Cancer Risk

September 03, 2020

There is no evidence that blood pressure lowering drugs increase the risk of cancer, according to a major new study.

FDA OKs Azacitidine Tablets for Acute Myeloid Leukemia

September 03, 2020

Oral azacitidine (Onureg; Celgene) is approved for patients in first remission with acute myeloid leukeimia.

Report: Specialty, Pediatric Drug Prices Projected to Rise Amid Pandemic

August 19, 2020

Oncology medical and infusion services have declined since the start of COVID-19.

Study Shows Promising Results for Olaparib and Durvalumab Combination Therapy for Certain Metastatic Breast Cancers

August 13, 2020

Results from the study showed antitumor activity and safety to be similar to olaparib and durvalumab monotherapy study findings.

Communicating Facts Can Help Boost HPV Vaccination Rates

August 12, 2020

Pharmacists should counsel patients on how taking steps now can prevent certain cancers later.

Study Compares Cost, Accessibility of Novel Cancer Drugs in US and India

August 07, 2020

The advent of generic and biosimilar medicines for novel treatments has helped bridge the gap in the delivery of cancer care between the United States and India, according to the study.

Expert Panel Updates Guidelines for Anti-Cancer Treatment Amid COVID-19

August 06, 2020

ESMO released changes to its recommendations on how to manage patients with cancer during the COVID-19 pandemic.

Study Shows Significant Decline in Cancer Screenings Amid Pandemic

August 03, 2020

A recent study evaluated the effects of the COVID-19 pandemic on normal cancer care activities, including cancer screening efforts.